RxDoctor Payments Data

Duane Dyson, MD

Emergency Medicine · Perth Amboy, NJNPI 1770585531

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Tactile Systems Technology Inc accounts for 76.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $365 and has fallen 90.1% since, to $36 in 2025.

$732in general payments, 2019–2025

Across 19 payments — averaging $38.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tactile Systems Technology Inc$562
  • Medtronic$145
  • Gilead$25
$180in research payments, 2019–2025

Across 1 payment — averaging $179.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Teva Pharmaceuticals USA, Inc.$180

What the payments were for

  • Food & beverage$732100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Tactile Systems Technology Inc16$562
Medtronic2$145
Gilead1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$732 in reported general payments places this provider in the 85th percentile of 1,505 emergency medicine providers in New Jersey.

See all emergency medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024
$288,766
Medicare patients
151
Services billed
805

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$2,915
Prednisone14$21

Paid to pharmacies, not to this prescriber.

Other emergency medicine in Perth Amboy

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →